DFX Intelligence
Data Factory
Reading the graph
Reading the graph
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Private Credit
Data as of (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Lender | Type | Borrowers | Facilities | Principal, latest | New borrowers, 4q | Last | Weakest basis |
|---|---|---|---|---|---|---|---|
| BLUE OWL CREDIT ADVISORS LLC | Credit provider | 1 | 1 | $215M | 0 | Sep 30, 2024 | portfolio name stem (inference) |
| Hercules Capital, Inc. | bdc |
| Borrower | Industry | Lenders | Facilities | Principal, latest | Next maturity | Attribution | Held |
|---|---|---|---|---|---|---|---|
| COMPASS Pathways plc | Drug Discovery & Development | 1 | 2 | $42.5M | Jan 1, 2031 | portfolio name stem (inference) | yes |
| Forge Biologics, Inc | Healthcare & Pharmaceuticals | 1 |
| 2 |
| $119M |
| 0 |
| Jun 30, 2026 |
| portfolio name stem (inference) |
| SLR CAPITAL PARTNERS, LLC | Credit provider | 1 | 2 | $107M | 0 | Dec 31, 2023 | portfolio name stem (inference) |
| BLUE OWL TECHNOLOGY CREDIT ADVISORS II LLC | Credit provider | 1 | 1 | $40.5M | 0 | Sep 30, 2024 | portfolio name stem (inference) |
| BLUE OWL TECHNOLOGY CREDIT ADVISORS LLC | Credit provider | 1 | 1 | $30.0M | 0 | Sep 30, 2024 | portfolio name stem (inference) |
| APOLLO INVESTMENT MANAGEMENT, L.P. | Credit provider | 1 | 1 | $26.7M | 0 | Sep 30, 2023 | portfolio name stem (inference) |
| Blue Owl Credit Advisers | Credit provider | 1 | 1 | $15.0M | 0 | Sep 30, 2024 | portfolio name stem (inference) |
| ARES CAPITAL MANAGEMENT LLC | Credit provider | 1 | 2 | $473,300 | 0 | Jun 30, 2025 | portfolio name stem (inference) |
| 2 |
| $26.7M |
| Dec 3, 2026 |
| portfolio name stem (inference) |
| no |
| ADMA Biologics Inc | n/a | 3 | 4 | $473,300 | Dec 1, 2027 | portfolio name stem (inference) | no |
| Sorrento Therapeutics, Inc | Biotechnology | 1 | 1 | n/a | n/a | portfolio name stem (inference) | yes |
| BridgeBio Pharma, Inc | Drug Discovery & Development | 11 | 3 | n/a | n/a | portfolio name stem (inference) | no |